GWMI
TXMD icon

Guardian Wealth Management (Illinois)’s TherapeuticsMD TXMD Stock Holding History

Guardian Wealth Management (Illinois)’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$2 – 193
2025
Q1 		$2 Hold
2
– – ﹤0.01% 228
2024
Q4 		$2 Hold
2
– – ﹤0.01% 229
2024
Q3 		$3 Hold
2
– – ﹤0.01% 239
2024
Q2 		$3 Hold
2
– – ﹤0.01% 244
2024
Q1 		$5 Hold
2
– – ﹤0.01% 244
2023
Q4 		$5 Hold
2
– – ﹤0.01% 258
2023
Q3 		$6 Hold
2
– – ﹤0.01% 226
2023
Q2 		$8 Hold
2
– – ﹤0.01% 228
2023
Q1 		$8 Hold
2
– – ﹤0.01% 243
2022
Q4 		$11 Hold
2
– – ﹤0.01% 251
2022
Q3 		$0 Hold
2
– – ﹤0.01% 241
2022
Q2 		$0 Hold
2
– – ﹤0.01% 233
2022
Q1 		$0 Hold
2
– – ﹤0.01% 237
2021
Q4 		$0 Buy
+2
New +$60 ﹤0.01% 227

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Guardian Wealth Management (Illinois)'s TXMD Position: Q2 2025 in Review

Guardian Wealth Management (Illinois) sold out of TherapeuticsMD (TXMD) in Q2 2025, closing a stake of 2 shares — an estimated $2 sold.

Guardian Wealth Management (Illinois) first reported a position in TXMD in Q4 2021 and held it in 14 quarters. The position peaked at $11 in Q4 2022. 42 funds tracked by Wall St. Rank hold TXMD as of Q2 2025.

  • Guardian Wealth Management (Illinois) reported no remaining TherapeuticsMD position as of Q2 2025 after selling out during the quarter.
  • Guardian Wealth Management (Illinois) sold 2 TherapeuticsMD shares in Q2 2025, an estimated $2.
  • Guardian Wealth Management (Illinois) first reported a position in TherapeuticsMD in Q4 2021 and held it in 14 quarters.
  • Guardian Wealth Management (Illinois)'s TherapeuticsMD position peaked at $11 in Q4 2022.
  • 42 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2025.

Based on Guardian Wealth Management (Illinois)'s 13F filing for Q2 2025, filed 14 Aug 2025.